Napatree Capital’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
DRZID
Napatree Capital's OGN Position: Q1 2025 in Review
Napatree Capital reduced its Organon & Co (OGN) stake by 4.5% in Q1 2025, selling an estimated $20.6K and leaving 28,515 shares worth $425K. The position accounts for 0.24% of the portfolio, ranked #115.
Napatree Capital first reported a position in OGN in Q4 2024 and has held it in 2 quarters since. The position peaked at $445K in Q4 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.
- Napatree Capital held 28,515 shares of Organon & Co worth $425K as of Q1 2025.
- Napatree Capital sold 1,339 Organon & Co shares in Q1 2025, an estimated $20.6K.
- Organon & Co made up 0.24% of Napatree Capital's portfolio in Q1 2025, its #115 holding.
- Napatree Capital first reported a position in Organon & Co in Q4 2024 and has held it in 2 quarters since.
- Napatree Capital's Organon & Co position peaked at $445K in Q4 2024.
- 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.
Based on Napatree Capital's 13F filing for Q1 2025, filed 2 May 2025.